Thesis TrackerLoading companies…
All companies
Loading…
Thesis TrackerThesis TrackerLoading…
Terragen Holdings (ASX:TGH) is an agricultural biologicals company that Saville Capital has followed as it seeks commercial validation. In March 2026, Saville reported Terragen released results of an independent assessment of its biostimulant Great Land Plus, showing a 12% increase in maize silage yield, equivalent to around $1,100 of extra gross revenue per hectare compared with standard growing practices. The result provides third-party evidence supporting the product's value for farmers. Terragen Holdings operates in the Materials sector within the Chemicals industry, and Thesis Tracker has captured 4 comments from 1 fund manager, Saville Capital. Founded in 1996 and headquartered in Coolum Beach, Queensland, Terragen develops and markets biological products, including soil and plant biostimulants and livestock probiotics such as Mylo, designed to improve agricultural productivity and sustainability for Australian farmers and graziers seeking alternatives to synthetic inputs.
Company figures as of 15 Oct 2026. For information only.
Fund managers including Saville Capital have invested in Terragen Holdings Ltd (ASX:TGH).
Saville Capital highlights independent trial results showing a 12% yield improvement in maize silage from Great Land Plus, providing evidence of a strong return for farmers that could support broader adoption and sales growth.
The available commentary does not set out specific risks, though as a small agricultural biologicals company Terragen depends on converting trial results into commercial sales growth.
Terragen Holdings Ltd. is an Australian-based company specializing in the development and marketing of agricultural probiotic products. Founded in 1996 and headquartered in Coolum Beach, the company serves the Australian and New Zealand markets. Terragen’s product portfolio includes Mylo Calf, Mylo Cow, and Great Land Plus. The firm focuses on delivering microbial-based agricultural solutions to improve farming outcomes. As a publicly traded entity, Terragen operates within the agricultural biotechnology sector, providing sustainable alternatives aimed at optimizing livestock health and soil productivity for its regional client base.
General information only. Thesis Tracker reports what named fund managers have published about ASX companies. It does not take into account your objectives, financial situation or needs, and is not financial product advice or a recommendation to buy, sell or hold any security.
11,356 comments from 164 managers on 761 companies, snapshot 15 Oct 2026.